Hematology TimesFDA approves drug for IDH1-mutated AMLJuly 23, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA approves biosimilar filgrastimJuly 22, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLALL
Hematology NewsFDA approves Nivestym, second biosimilar to NeupogenJuly 20, 2018AMLPatient & Survivor CareLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDA approves IDH1 inhibitor for relapsed/refractory AMLJuly 20, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsIbrutinib stacks up well on safety in pooled analysisJuly 20, 2018CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology TimesDiabetics have higher risk of hematologic, other cancersJuly 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Hematology TimesStudy suggests dasatinib could treat AML, JMMLJuly 18, 2018Leukemia, Myelodysplasia, TransplantationPediatricsAML
Hematology NewsLab results may help predict complications in ALL treatmentJuly 17, 2018ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesExplaining enasidenib resistance in AMLJuly 17, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesMutations linked to higher risk of SNs in CCSsJuly 16, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
CAR T Therapy: From Bench to Bedside and BackJuly 15, 2018AnemiaLeukemia, Myelodysplasia, TransplantationALLAMLCellular TherapyLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsGenentech submits sNDA for venetoclax in untreated AMLJuly 12, 2018AMLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology TimesProtein could be target for MLL-rearranged AMLJuly 12, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesIdentifying patients with a high risk of AMLJuly 11, 2018Leukemia, Myelodysplasia, TransplantationAML
